share_log

华海药业:西格列汀二甲双胍片获美国FDA暂时批准文号

Zhejiang Huahai Pharmaceutical: The saxagliptin metformin tablets have received temporary approval from the USA FDA.

Breakings ·  Mar 17 07:58

Zhejiang Huahai Pharmaceutical announced that the abbreviated new drug application (ANDA) for the saxagliptin metformin tablets submitted to the USA FDA has received temporary approval. This pharmaceutical is mainly used for the treatment of type 2 diabetes and was developed by MSD SUB MERCK, first launched in the USA in March 2007.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Comment Comment · Views 243

Recommended

Write a comment

Statement

This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.